Orange Book product · Generic (ANDA)
HEPARIN SODIUM
HEPARIN SODIUM
At a glance
Feb 24, 2020
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 24, 2020
6 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
HEPARIN SODIUM
Strength
20,000 UNITS/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 211004
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HEPARIN SODIUM
- 2011HEPARIN SODIUMBrand (NDA)
NDA 201370 · PFIZER
- —HEPARIN LOCK FLUSHBrand (NDA)
NDA 005264 · HOSPIRA
- —HEPARIN LOCK FLUSHBrand (NDA)
NDA 017346 · PARKE DAVIS
- —HEPARIN SODIUMBrand (NDA)
NDA 017033 · ABRAXIS PHARM
- —HEPARIN SODIUMBrand (NDA)
NDA 017979 · ABRAXIS PHARM
- —HEPARIN SODIUMBrand (NDA)
NDA 000552 · ASPEN GLOBAL INC
- —HEPARIN SODIUMBrand (NDA)
NDA 017130 · CHAMBERLIN PARENTERL
- —HEPARIN SODIUMBrand (NDA)
NDA 017540 · DELL LABS
- —HEPARIN SODIUMBrand (NDA)
NDA 017064 · DR REDDYS
- —HEPARIN SODIUMBrand (NDA)
NDA 017486 · EPIC PHARMA LLC
- —HEPARIN SODIUMBrand (NDA)
NDA 017029 · FRESENIUS KABI USA
- —HEPARIN SODIUMBrand (NDA)
NDA 017651 · FRESENIUS KABI USA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
